Shenzhen Shangtang Technology Co., Ltd. – Trademark Portfolio

Entity Type: 16

Shenzhen Shangtang Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SANGTEK. The owner is based in Shenzhen.

Room 310, 3rd Floor, Block A, Jindingsheng Science and Technology Park, Qinghu Community, Longhua Street, Longhua District

Shenzhen 518000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SANGTEK
SANGTEK
Registered 2025

Trademark Classifications

Shenzhen Shangtang Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Shenzhen Shangtang Technology Co., Ltd. have?

Shenzhen Shangtang Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shenzhen Shangtang Technology Co., Ltd. file in?

Shenzhen Shangtang Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Shenzhen Shangtang Technology Co., Ltd.'s most well-known trademarks?

Shenzhen Shangtang Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as SANGTEK. These are among 1 currently registered trademark in the portfolio.

What is Shenzhen Shangtang Technology Co., Ltd.'s trademark registration success rate?

Shenzhen Shangtang Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.